Intranasal Esketamine

DRUG3 trials

Sponsors

Janssen Research & Development, LLC, Psych Atlanta, Sun Fei

Conditions

Autism Spectrum DisorderHealthyTreatment Resistant Depression

Phase 1

A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants

CompletedNCT02737605

Janssen Research & Development, LLCHealthy

Start: 2016-07-01End: 2017-02-23Updated: 2018-04-11

Unknown Phase

Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine

CompletedNCT04856124

Psych AtlantaTreatment Resistant Depression

Start: 2018-09-01End: 2021-03-01Updated: 2021-04-23

The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder

Not yet recruitingNCT07324057

Sun FeiAutism Spectrum Disorder

Start: 2026-02-01End: 2027-11-30Target: 234Updated: 2026-01-07